| Literature DB >> 27928073 |
Jin Park1,2, Soo-Han Woo2, Chang-Seop Lee3,1.
Abstract
Entities:
Mesh:
Year: 2016 PMID: 27928073 PMCID: PMC5154431 DOI: 10.4269/ajtmh.16-0583
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Figure 1.(A) Three days from symptom onset (SE03): central yellowish vesicle with mild whitish scale, and peripheral erythematous patch. (B) SE05: central vesicle turned into brown to black-colored crusts and scales are increased. (C) SE06: formation of typical eschar lesion having central black crusts and conspicuous erythematous patch with overlaying scale. (D) SE08: well-established eschar composed of three concentric components; innermost black crust outlined by inner scaly line, middle erythematous patch, and outermost whitish scaly layer. (E) SE14: shrinkage of central crusts and diminished peripheral scale. (F) SE17: central crust completely disappeared, and changed into central scar-like whitish area with peripheral erythematous area showing prominent vascular pattern. (G) SE20: dull reddish-brown hyperpigmentation.